scholarly article | Q13442814 |
P50 | author | Christian Diener | Q41044712 |
Osbaldo Resendis | Q55860492 | ||
P2093 | author name string | Christian Diener | |
Osbaldo Resendis-Antonio | |||
P2860 | cites work | Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 |
NCBI GEO: archive for functional genomics data sets--update | Q24595691 | ||
Comprehensive molecular portraits of human breast tumours | Q24630844 | ||
Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions | Q26261171 | ||
Modeling metabolism: a window toward a comprehensive interpretation of networks in cancer | Q27021633 | ||
Comprehensive molecular characterization of clear cell renal cell carcinoma | Q27852374 | ||
The BioMart community portal: an innovative alternative to large, centralized data repositories | Q27949361 | ||
Metabolic pathways promoting cancer cell survival and growth | Q28086940 | ||
What is flux balance analysis? | Q28275348 | ||
Energy metabolism in tumor cells | Q28288377 | ||
Reconstruction of Tissue-Specific Metabolic Networks Using CORDA | Q28388815 | ||
Context-specific metabolic networks are consistent with experiments | Q28472711 | ||
Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT | Q28483779 | ||
Systematic evaluation of methods for integration of transcriptomic data into constraint-based models of metabolism | Q28538197 | ||
Exon array analyses across the NCI-60 reveal potential regulation of TOP1 by transcription pausing at guanosine quartets in the first intron | Q28749651 | ||
PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes | Q29547229 | ||
Regularization Paths for Generalized Linear Models via Coordinate Descent | Q29614491 | ||
The NCI60 human tumour cell line anticancer drug screen | Q29614975 | ||
The causes and consequences of genetic heterogeneity in cancer evolution | Q29615848 | ||
Oxidative stress, inflammation, and cancer: how are they linked? | Q29616835 | ||
A gene expression database for the molecular pharmacology of cancer | Q29619242 | ||
Predicting cellular growth from gene expression signatures | Q33396962 | ||
Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling | Q33597307 | ||
Omic data from evolved E. coli are consistent with computed optimal growth from genome-scale models | Q33642720 | ||
Modeling core metabolism in cancer cells: surveying the topology underlying the Warburg effect | Q33682181 | ||
Computationally efficient flux variability analysis | Q33709846 | ||
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin | Q34123261 | ||
A framework for oligonucleotide microarray preprocessing. | Q34149103 | ||
Fructose-1,6-bisphosphatase opposes renal carcinoma progression | Q34173576 | ||
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development | Q34315320 | ||
Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma | Q34405226 | ||
Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE | Q34509501 | ||
Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer | Q34545824 | ||
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma | Q34677263 | ||
COBRApy: COnstraints-Based Reconstruction and Analysis for Python | Q34911268 | ||
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer | Q35587470 | ||
Human metabolic atlas: an online resource for human metabolism | Q35713056 | ||
Modeling cancer metabolism on a genome scale | Q35850350 | ||
Metabolic Heterogeneity in Human Lung Tumors. | Q36578111 | ||
Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism | Q36852748 | ||
Intratumoral Heterogeneity of the Epigenome. | Q36854908 | ||
Heterogeneity of tumor-induced gene expression changes in the human metabolic network | Q36927094 | ||
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer | Q36967938 | ||
TAp73 enhances the pentose phosphate pathway and supports cell proliferation | Q37071124 | ||
Cellular fatty acid metabolism and cancer | Q37092913 | ||
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq | Q37094024 | ||
Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity | Q37094872 | ||
Cancer metabolism: fatty acid oxidation in the limelight | Q37155867 | ||
The complex role of branched chain amino acids in diabetes and cancer | Q37608822 | ||
Oxidative stress and cancer: an overview | Q38057533 | ||
The pentose phosphate pathway and cancer | Q38231069 | ||
Personalized Whole-Cell Kinetic Models of Metabolism for Discovery in Genomics and Pharmacodynamics | Q39803501 | ||
Pan-cancer analysis of the extent and consequences of intratumor heterogeneity. | Q40139573 | ||
BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder | Q40738932 | ||
Human breast cancer cells and normal mammary epithelial cells: retinol metabolism and growth inhibition by the retinol metabolite 4-oxoretinol. | Q41086451 | ||
Metabolic Remodeling in Times of Stress: Who Shoots Faster than His Shadow? | Q52922856 | ||
P921 | main subject | biopsy | Q179991 |
P304 | page(s) | 644 | |
P577 | publication date | 2016-12-27 | |
P1433 | published in | Frontiers in Physiology | Q2434141 |
P1476 | title | Personalized Prediction of Proliferation Rates and Metabolic Liabilities in Cancer Biopsies | |
P478 | volume | 7 |